Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 6, March

Preface [Hot Topic: Emerging Kinase Targets and Kinase Inhibitor Discovery Methods (Guest Editor: Gary McCort)]

Volume:11   Issue: 6
Pp: ii-ii
Gary McCort
DOI: 10.2174/09298673104090600ii
Published on: 01 March, 2012

Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights

Volume:11   Issue: 6
Pp: 663-673
M. Cherry and D. H. Williams
DOI: 10.2174/0929867043455792
Published on: 01 March, 2012

Stochastic Algorithm for Kinase Homology Model Construction

Volume:11   Issue: 6
Pp: 675-692
A. Rayan, E. Noy, D. Chema, A. Levitzki and A. Goldblum
DOI: 10.2174/0929867043455701
Published on: 01 March, 2012

Virtual Screening for Kinase Targets

Volume:11   Issue: 6
Pp: 693-707
Ingo Muegge and Istvan J. Enyedy
DOI: 10.2174/0929867043455684
Published on: 01 March, 2012

Property-Based Design of KDR Kinase Inhibitors

Volume:11   Issue: 6
Pp: 709-719
Mark E. Fraley, William F. Hoffman, Kenneth L. Arrington, Randy W. Hungate, George D. Hartman, Rosemary C. McFall, Kathleen E. Coll, Keith Rickert, Kenneth A. Thomas and Georgia B. McGaughey
DOI: 10.2174/0929867043455729
Published on: 01 March, 2012

AlphaScreen™ Kinase HTS Platforms

Volume:11   Issue: 6
Pp: 721-730
Greg Warner, Chantal Illy, Liliana Pedro, Philippe Roby and Roger Bosse
DOI: 10.2174/0929867043455693
Published on: 01 March, 2012

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

Volume:11   Issue: 6
Pp: 731-745
T. L. Underiner, B. Ruggeri and D. E. Gingrich
DOI: 10.2174/0929867043455756
Published on: 01 March, 2012

4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck

Volume:11   Issue: 6
Pp: 747-753
D. F.C. Moffat, R. A. Allen, S. E. Rapecki, P. D. Davis, J. O'Connell, M. C. Hutchings, M. A. King, B. A. Boyce and M. J. Perry
DOI: 10.2174/0929867043455710
Published on: 01 March, 2012

GSK-3 Inhibitors: Discoveries and Developments

Volume:11   Issue: 6
Pp: 755-763
M. Alonso and A. Martinez
DOI: 10.2174/0929867043455738
Published on: 01 March, 2012

Challenges in Antimicrobial Drug Discovery and the Potential of Nucleoside Antibiotics

Volume:11   Issue: 6
Pp: 775-793
Suguna Rachakonda and Leanne Cartee
DOI: 10.2174/0929867043455774
Published on: 01 March, 2012

Retinoids and Retinoid Receptors in the Control of Energy Balance: Novel Pharmacological Strategies in Obesity and Diabetes

Volume:11   Issue: 6
Pp: 795-805
F. Villarroya, R. Iglesias and M. Giralt
DOI: 10.2174/0929867043455747
Published on: 01 March, 2012